AbstractChiral intermediates were prepared by biocatalytic processes for the chemical synthesis of β‐3‐receptor agonists. These include: (i) the microbial reduction of 4‐benzyloxy‐3‐methanesulfonylamino‐2′‐bromoacetophenone 1 to the corresponding (R)‐alcohol 2 by Spingomonas paucimobilis SC 16113. In the biotransformation process, a reaction yield of >85% and an optical purity of 99.5% were obtained for the desired (R)‐alcohol 2; (ii) the enzymatic resolution of racemic α‐methyl phenylalanine amide, 3, and α‐methyl‐4‐hydroxy‐phenylalanine amide, 5, by amidase from Mycobacterium neoaurum ATCC 25795 to prepare the corresponding (S)‐amino acids 4 and 6. Reaction yields of 49.9 and 49 M% (theoretical maximum yield 50 M%) and optical purities of 99 and 94% were obtained for the desired (S)‐amino acids 4 and 6, respectively; (iii) the asymmetric hydrolysis of methyl‐(4‐methoxyphenyl)‐propanedioic acid, ethyl diester, 7, to the corresponding (S)‐monoester 8 by pig liver esterase. A reaction yield of 96 M% and an optical purity of 96% were obtained for (S)‐monoester 8 when reactions were carried out in a biphasic system containing 10% ethanol at 10°C.
[EN] D-METYROSINE COMPOSITIONS AND METHODS FOR PREPARING SAME<br/>[FR] COMPOSITIONS DE D-MÉTYROSINE ET LEURS PROCÉDÉS DE PRÉPARATION
申请人:TYME INC
公开号:WO2020197875A1
公开(公告)日:2020-10-01
The disclosure provides processes for preparing a compound of formula I, comprising reacting a compound of formula II with an aqueous acid in a solvent and at a temperature sufficient for at least about 48 hours to produce a compound of formula I: wherein, R1-R5 are defined herein. Also provided are D-metyrosine prepared according to the processes described herein and compositions comprising the D-metyrosine provided herein.
Provided herein are compositions including diastereomers in substantially diastereomerically pure form and enantiomers in substantially enantiomerically pure form, and processes for preparing them and converting them to metyrosine.
[EN] STEREOSELECTIVE SYNTHESIS OF METYROSINE<br/>[FR] SYNTHÈSE STÉRÉOSÉLECTIVE DE MÉTYROSINE
申请人:ATON PHARMA INC
公开号:WO2011053835A1
公开(公告)日:2011-05-05
Provided herein are compositions including diastereomers in substantially diastereomerically pure form and enantiomers in substantially enantiomerically pure form, and processes for preparing them and converting them to metyrosine.